Replies to post #94110 on Ayala Pharmaceuticals Inc (ADXS)

[blueyedcatch]

Very possible.

[fbg0316]

"...assuming Merck wants to make a deal."

That is a huge assumption that looks unlikely, because Merck has had a non-paying collaboration with ADXS since 2014 supplying Keytruda and since then ADXS has generated combo trial data for both PSA and AXAL (with Astra Zeneca). The iron has been hot in terms of large companies locking in rights for promising small biotech platforms, and Merck has not stepped up to strike anything with ADXS.